Loading clinical trials...
Loading clinical trials...
A Phase I/II Study of Carboplatin/Nab-Paclitaxel and Pembrolizumab for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions
Interventions
Carboplatin
Nab-paclitaxel
+2 more
Locations
5
United States
City of Hope
Duarte, California, United States
Northwestern University, Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
IU Health Central Indiana Cancer Center
Indianapolis, Indiana, United States
University of Virginia Cancer Center
Charlottesville, Virginia, United States
Start Date
June 4, 2015
Primary Completion Date
April 14, 2022
Completion Date
April 14, 2022
Last Updated
May 23, 2023
NCT06043817
NCT07144280
NCT07431827
NCT06758401
NCT06427941
NCT05910827
Lead Sponsor
Nisha Mohindra, MD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions